Answers are grounded in this paper and cite their sources.
Metabolic syndrome (MetS) is a cluster of medical conditions and risk factors correlating with insulin resistance that increase the risk of developing cardiometabolic health problems. The specific criteria for diagnosing MetS vary among different medical organizations but are typically based on the evaluation of abdominal obesity, high blood pressure, hyperglycemia, and dyslipidemia. A unique, quantitative and independent estimation of the risk of MetS based only on quantitative biomarkers is highly desirable for the comparison between patients and to study the individual progression of the disease in a quantitative manner.
No takes yet. Share an insight, caveat, or question.
Gil‐Redondo et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: